Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-10-02

FDA Approved: TRIBENZOR — Supplemental Application (Cosette Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved a supplemental application for TRIBENZOR (olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide) submitted by Cosette Pharmaceuticals, I…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TRIBENZOR (OLMESARTAN MEDOXOMIL / AMLODIPINE BESYLATE / HYDROCHLOROTHIAZIDE)

Snippet

SUPPL AP for TRIBENZOR (OLMESARTAN MEDOXOMIL / AMLODIPINE BESYLATE / HYDROCHLOROTHIAZIDE)